Similar to CaSR expression in metastatic prostate cancers, β1-containing integrins have been shown to be constitutively activated in prostate cancer cell lines with high metastatic potential, but not in cancer cell lines with low metastatic potential (Lee et al., 2013). This evidence concerns the gene CASR and prostate carcinoma.